Medindia

X

CryoLife to Present at 19th Annual Piper Jaffray Health Care Conference in New York

Wednesday, November 21, 2007 General News J E 4
Advertisement
ATLANTA, Nov. 20 CryoLife, Inc. (NYSE: CRY), abiomaterials, medical device and tissue processing company, announced todaythat it is scheduled to participate in the 19th Annual Piper Jaffray HealthCare Conference at the Pierre Hotel in New York City on Tuesday, November 27,2007.

Steven G. Anderson, president and CEO of CryoLife, Inc. will deliver theCompany's presentation beginning at approximately 1:30 p.m. EST.

CryoLife's live presentation may be accessed through its Web site,www.cryolife.com, on the Investor Relations page. An archived copy of thepresentation will be available for 30 days on the same Web site.

About CryoLife

Founded in 1984, CryoLife, Inc. is a leader in the processing anddistribution of implantable living human tissues for use in cardiac andvascular surgeries throughout the United States and Canada. The Company'sBioGlue(R) Surgical Adhesive is FDA approved as an adjunct to sutures andstaples for use in adult patients in open surgical repair of large vessels.BioGlue is also CE marked in the European Community and approved in Canada andAustralia for use in soft tissue repair. The Company also distributes theCryoLife-O'Brien(R) stentless porcine heart valve, which is CE marked fordistribution within the European Community.

For additional information about the Company, visit CryoLife's Web Site:http://www.cryolife.com.Media Contacts: D. Ashley Lee Executive Vice President, Chief Financial Officer and Chief Operating Officer Phone: 770-419-3355 Katie Brazel Fleishman Hillard Phone: 404-739-0150

SOURCE CryoLife, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
ACS Announces $18.5 Million Contract with Idaho Me...
S
Kewaunee Scientific Announces Significantly Improv...